Sign Up Today and Learn More About 3D Cell Bioprinting Consortium Stock
Invest in or calculate the value of your shares in 3D Cell Bioprinting Consortium or other pre-IPO companies through EquityZen's platform.
3D Cell Bioprinting Consortium Stock (TDCC)
Group of companies focused on offering the complete solution for tissue engineering
About 3D Cell Bioprinting Consortium Stock
Founded
2016
Headquarters
Marlborough, MA, US
Industries
Messaging and Telecommunications, Content and Publishing, Sports
3D Cell Bioprinting Consortium Press Mentions
Stay in the know about the latest news on 3D Cell Bioprinting Consortium
Bioprinting Consortium Launches
cellapplications • Feb 06, 2017
3D Cell Bioprinting Consortium Management
Leadership team at 3D Cell Bioprinting Consortium
President & COO, Digilab, Inc.
John Moore
Consortium Member
John Moore
Join now and verify your accreditation status to gain access to:
- 3D Cell Bioprinting Consortium Current Valuation
- 3D Cell Bioprinting Consortium Stock Price
- 3D Cell Bioprinting Consortium Management
- Available deals in 3D Cell Bioprinting Consortium and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- 3D Cell Bioprinting Consortium Cap Table and Funding History by Share Class and Liquidity Preferences
- 3D Cell Bioprinting Consortium Revenue and Financials
- 3D Cell Bioprinting Consortium Highlights
- 3D Cell Bioprinting Consortium Business Model
- 3D Cell Bioprinting Consortium Risk Factors
- 3D Cell Bioprinting Consortium Research Report from SACRA Research
Trading 3D Cell Bioprinting Consortium Stock
How to invest in 3D Cell Bioprinting Consortium stock?
Accredited investors can buy pre-IPO stock in companies like 3D Cell Bioprinting Consortium through EquityZen funds. These investments are made available by existing 3D Cell Bioprinting Consortium shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell 3D Cell Bioprinting Consortium stock?
Shareholders can sell their 3D Cell Bioprinting Consortium stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
